Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Epstein RL, Wang J, White LF, Kapadia SN, Morgan JR, Bao Y, Linas BP. Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured. Am J Prev Med. 2022 Sep;63(3):e87-e98. doi: 10.1016/j.amepre.2022.03.010. Epub 2022 Jun 18. PubMed PMID: 35725599; NIHMSID:NIHMS1827979.
Crable E, Jones DK, Walley AY, Hicks JM, Benintendi A, Drainoni ML. How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences. J Health Polit Policy Law. 2022 Aug 1;47(4):497-518. doi: 10.1215/03616878-9716740. PubMed PMID: 35044466.
Nolen S, Zang X, Chatterjee A, Behrends CN, Green TC, Kumar A, Linas BP, Morgan JR, Murphy SM, Walley AY, Yan S, Schackman BR, Marshall BDL. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction. 2022 May;117(5):1372-1381. doi: 10.1111/add.15759. Epub 2021 Dec 5. PubMed PMID: 34825427; PubMed Central PMCID: PMC8983544.
Harris MTH, Lambert AM, Maschke AD, Bagley SM, Walley AY, Gunn CM. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston. J Subst Abuse Treat. 2022 Apr;135:108655. doi: 10.1016/j.jsat.2021.108655. Epub 2021 Nov 4. PubMed PMID: 34772604; PubMed Central PMCID: PMC8576611.
Morgan JR, Quinn EK, Chaisson CE, Ciemins E, Stempniewicz N, White LF, Linas BP, Walley AY, LaRochelle MR. Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design. Med Care. 2022 Mar 1;60(3):256-263. doi: 10.1097/MLR.0000000000001689. PubMed PMID: 35026792; PubMed Central PMCID: PMC8852217.
Beaugard CA, Chui KKH, Larochelle MR, Young LD, Walley AY, Stopka TJ. Abrupt Discontinuation From Long-Term Opioid Therapy in Massachusetts, 2015-2018. Am J Prev Med. 2022 Mar;62(3):404-413. doi: 10.1016/j.amepre.2021.09.015. Epub 2021 Nov 24. PubMed PMID: 34838368.
Pollini RA, Ozga JE, Joyce R, Xuan Z, Walley AY. Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial. Drug Alcohol Depend. 2022 Feb 1;231:109259. doi: 10.1016/j.drugalcdep.2021.109259. Epub 2021 Dec 31. PubMed PMID: 34998246; PubMed Central PMCID: PMC8810724.
Colasanti JA, Del Rio C, Cheng DM, Liebschutz JM, Lira MC, Tsui JI, Walley AY, Forman LS, Root C, Shanahan CW, Bridden CL, Harris C, Outlaw K, Armstrong WS, Samet JH. A collaborative care intervention to improve opioid prescribing among providers caring for persons with HIV: Impact on satisfaction, confidence, and trust. Drug Alcohol Depend. 2022 Feb 1;231:109250. doi: 10.1016/j.drugalcdep.2021.109250. Epub 2021 Dec 29. PubMed PMID: 34998255.
Crable EL, Benintendi A, Jones DK, Walley AY, Hicks JM, Drainoni ML. Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment. Implement Sci. 2022 Jan 6;17(1):3. doi: 10.1186/s13012-021-01182-4. PubMed PMID: 34991638; PubMed Central PMCID: PMC8734202.
Raja A, Heeren TC, Walley AY, Winter MR, Mesic A, Saitz R. Food insecurity and substance use in people with HIV infection and substance use disorder. Subst Abus. 2022;43(1):104-112. doi: 10.1080/08897077.2020.1748164. Epub 2020 May 6. PubMed PMID: 32374225; PubMed Central PMCID: PMC7644575.
Laks J, Kehoe J, Farrell NM, Komaromy M, Kolodziej J, Walley AY, Taylor JL. Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule. Addict Sci Clin Pract. 2021 Dec 28;16(1):73. doi: 10.1186/s13722-021-00279-x. PubMed PMID: 34961554; PubMed Central PMCID: PMC8712102.
Zang X, Macmadu A, Krieger MS, Behrends CN, Green TC, Morgan JR, Murphy SM, Nolen S, Walley AY, Schackman BR, Marshall BD. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. Int J Drug Policy. 2021 Dec;98:103435. doi: 10.1016/j.drugpo.2021.103435. Epub 2021 Sep 3. PubMed PMID: 34482264; PubMed Central PMCID: PMC8671216.
Harris MT, Seliga RK, Fairbairn N, Nolan S, Walley AY, Weinstein ZM, Turnbull J. Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing. Int J Drug Policy. 2021 Dec;98:103400. doi: 10.1016/j.drugpo.2021.103400. Epub 2021 Aug 30. PubMed PMID: 34469781; PubMed Central PMCID: PMC8881087.
Park TW, Sikov J, dellaBitta V, Saitz R, Walley AY, Drainoni ML. "It could potentially be dangerous... but nothing else has seemed to help me.": Patient and clinician perspectives on benzodiazepine use in opioid agonist treatment. J Subst Abuse Treat. 2021 Dec;131:108455. doi: 10.1016/j.jsat.2021.108455. Epub 2021 Apr 30. PubMed PMID: 34098286; PubMed Central PMCID: PMC8556389.
Kimmel SD, Kim JH, Kalesan B, Samet JH, Walley AY, Larochelle MR. Against Medical Advice Discharges in Injection and Non-injection Drug Use-associated Infective Endocarditis: A Nationwide Cohort Study. Clin Infect Dis. 2021 Nov 2;73(9):e2484-e2492. doi: 10.1093/cid/ciaa1126. PubMed PMID: 32756935; PubMed Central PMCID: PMC8563193.
Harvey L, Taylor JL, Assoumou SA, Kehoe J, Schechter-Perkins EM, Bernstein E, Walley AY. Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic. J Addict Med. 2021 Nov-Dec 01;15(6):461-467. doi: 10.1097/ADM.0000000000000801. PubMed PMID: 34734572; PubMed Central PMCID: PMC8569143.
Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2021 Nov-Dec 01;15(6):448-451. doi: 10.1097/ADM.0000000000000791. PubMed PMID: 33298750; PubMed Central PMCID: PMC8562917.
Thakrar AP, Furfaro D, Keller S, Graddy R, Buresh M, Feldman L. A Resident-Led Intervention to Increase Initiation of Buprenorphine Maintenance for Hospitalized Patients With Opioid Use Disorder. J Hosp Med. 2021 Jun;16(6):339-344. doi: 10.12788/jhm.3544. PubMed PMID: 34129484; PubMed Central PMCID: PMC8191766.
Kimmel SD, Walley AY, Lodi S, Forman LS, Liebschutz JM, Lira MC, Kim TW, Del Rio C, Samet JH, Tsui JI. Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy. AIDS. 2021 Mar 15;35(4):697-700. doi: 10.1097/QAD.0000000000002803. PubMed PMID: 33587441; PubMed Central PMCID: PMC7904637.
Fujita AW, LaRosa A, Carter A. Treating Withdrawal and Pain in Inpatients With Opioid Use Disorder: A Brief Educational Intervention for Internal Medicine Residents. MedEdPORTAL. 2021 Mar 10;17:11123. doi: 10.15766/mep_2374-8265.11123. PubMed PMID: 33768154; PubMed Central PMCID: PMC7970646.
Kimmel SD, Rosenmoss S, Bearnot B, Larochelle M, Walley AY. Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts. J Addict Med. 2021 Jan-Feb 01;15(1):20-26. doi: 10.1097/ADM.0000000000000693. PubMed PMID: 32675798; PubMed Central PMCID: PMC7859880.
Motavalli D, Taylor JL, Childs E, Valente PK, Salhaney P, Olson J, Biancarelli DL, Edeza A, Earlywine JJ, Marshall BDL, Drainoni ML, Mimiaga MJ, Biello KB, Bazzi AR. "Health Is on the Back Burner:" Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs. J Gen Intern Med. 2021 Jan;36(1):129-137. doi: 10.1007/s11606-020-06201-6. Epub 2020 Sep 11. PubMed PMID: 32918199; PubMed Central PMCID: PMC7858998.
Kimmel SD, Miller NS. The Clinical Microbiology Laboratory and the Opioid Epidemic: Challenges and Opportunities. Infect Dis Clin North Am. 2020 Sep;34(3):465-478. doi: 10.1016/j.idc.2020.06.005. Review. PubMed PMID: 32782096; PubMed Central PMCID: PMC7428057.
Kimmel SD, Del Rio C. Improving Outcomes for People With Injection Drug-related Endocarditis: Are Medications for Opioid Use Disorder Enough?. J Addict Med. 2020 Jul/Aug;14(4):280-0. doi: 10.1097/ADM.0000000000000573. PubMed PMID: 31634203; PubMed Central PMCID: PMC7165029.
Weinstein ZM, Cheng DM, D'Amico MJ, Forman LS, Regan D, Yurkovic A, Samet JH, Walley AY. Inpatient addiction consultation and post-discharge 30-day acute care utilization. Drug Alcohol Depend. 2020 May 25;213:108081. doi: 10.1016/j.drugalcdep.2020.108081. [Epub ahead of print] PubMed PMID: 32485657; PubMed Central PMCID: PMC7371521.
Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019 Dec 10;322(22):2245-2248. doi: 10.1001/jama.2019.16196. PubMed PMID: 31821424; PubMed Central PMCID: PMC7081751.
D'Amico MJ, Walley AY, Cheng DM, Forman LS, Regan D, Yurkovic A, Samet JH, Weinstein ZM. Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study. J Subst Abuse Treat. 2019 Nov;106:35-42. doi: 10.1016/j.jsat.2019.08.013. Epub 2019 Aug 20. PubMed PMID: 31540609; PubMed Central PMCID: PMC6756179.
Colasanti J, Lira MC, Cheng DM, Liebschutz JM, Tsui JI, Forman LS, Sullivan M, Walley AY, Bridden C, Root C, Podolsky M, Abrams C, Outlaw K, Harris CE, Armstrong WS, Samet JH, Del Rio C. Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients' Perspectives on Risks, Monitoring, and Guidelines. Clin Infect Dis. 2019 Jan 7;68(2):291-297. doi: 10.1093/cid/ciy452. PubMed PMID: 29860411; PubMed Central PMCID: PMC6594413.
Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data. Ann Intern Med. 2019 Jan 1;170(1):31-40. doi: 10.7326/M18-2124. Epub 2018 Dec 4. PubMed PMID: 30508432; PubMed Central PMCID: PMC6548681.
Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP. Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health. 2018 Dec;108(12):1675-1681. doi: 10.2105/AJPH.2018.304673. Epub 2018 Oct 25. PubMed PMID: 30359112; PubMed Central PMCID: PMC6236756.
Hadland SE, Bagley SM, Rodean J, Silverstein M, Levy S, Larochelle MR, Samet JH, Zima BT. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. JAMA Pediatr. 2018 Nov 1;172(11):1029-1037. doi: 10.1001/jamapediatrics.2018.2143. PubMed PMID: 30208470; PubMed Central PMCID: PMC6218311.
Bagley SM, Cheng DM, Winter M, Alford DP, LaBelle C, Walley AY, Samet JH. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Drug Alcohol Depend. 2018 Nov 1;192:245-249. doi: 10.1016/j.drugalcdep.2018.08.010. Epub 2018 Sep 25. PubMed PMID: 30290291; PubMed Central PMCID: PMC6291245.
Rose AJ, Bernson D, Chui KKH, Land T, Walley AY, LaRochelle MR, Stein BD, Stopka TJ. Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015. J Gen Intern Med. 2018 Sep;33(9):1512-1519. doi: 10.1007/s11606-018-4532-5. Epub 2018 Jun 14. PubMed PMID: 29948815; PubMed Central PMCID: PMC6109008.
Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, Bagley SM, Liebschutz JM, Walley AY. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. Ann Intern Med. 2018 Aug 7;169(3):137-145. doi: 10.7326/M17-3107. Epub 2018 Jun 19. PubMed PMID: 29913516; PubMed Central PMCID: PMC6387681.
Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, Labelle C, Samet JH. Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend. 2018 Aug 1;189:166-171. doi: 10.1016/j.drugalcdep.2018.05.010. Epub 2018 Jun 19. PubMed PMID: 29958128; PubMed Central PMCID: PMC6139651.
Saitz R, Mesic A, Ventura AS, Winter MR, Heeren TC, Sullivan MM, Walley AY, Patts GJ, Meli SM, Holick MF, Kim TW, Bryant KJ, Samet JH. Alcohol Consumption and Bone Mineral Density in People with HIV and Substance Use Disorder: A Prospective Cohort Study. Alcohol Clin Exp Res. 2018 Jun 6;. doi: 10.1111/acer.13801. [Epub ahead of print] PubMed PMID: 29873812; PubMed Central PMCID: PMC6281811.
Lasser KE, Hanchate AD, McCormick D, Walley AY, Saitz R, Lin MY, Kressin NR. Massachusetts Health Reform's Effect on Hospitalizations with Substance Use Disorder-Related Diagnoses. Health Serv Res. 2018 Jun;53(3):1727-1744. doi: 10.1111/1475-6773.12710. Epub 2017 May 19. PubMed PMID: 28523674; PubMed Central PMCID: PMC5980373.
Taylor JL, Rapoport AB, Rowley CF, Mukamal KJ, Stead W. An opioid overdose curriculum for medical residents: Impact on naloxone prescribing, knowledge, and attitudes. Subst Abus. 2018;39(3):371-376. doi: 10.1080/08897077.2018.1439800. Epub 2018 May 15. PubMed PMID: 29432074; PubMed Central PMCID: PMC8916048.
Bagley SM, Forman LS, Ruiz S, Cranston K, Walley AY. Expanding access to naloxone for family members: The Massachusetts experience. Drug Alcohol Rev. 2018 May;37(4):480-486. doi: 10.1111/dar.12551. Epub 2017 Apr 20. PubMed PMID: 28429378.
Alford DP, Carney BL, Jackson AH, Brett B, Bridden C, Winter M, Samet JH. Promoting addiction medicine teaching through functional mentoring by co-training generalist chief residents with faculty mentors. Subst Abus. 2018;39(3):377-383. doi: 10.1080/08897077.2018.1439799. Epub 2018 Apr 5. PubMed PMID: 29452056; PubMed Central PMCID: PMC6128783.
Formica SW, Apsler R, Wilkins L, Ruiz S, Reilly B, Walley AY. Post opioid overdose outreach by public health and public safety agencies: Exploration of emerging programs in Massachusetts. Int J Drug Policy. 2018 Apr;54:43-50. doi: 10.1016/j.drugpo.2018.01.001. Epub 2018 Feb 8. PubMed PMID: 29414484.
Lasser KE, Lunze K, Cheng DM, Blokhina E, Walley AY, Tindle HA, Quinn E, Gnatienko N, Krupitsky E, Samet JH. Depression and smoking characteristics among HIV-positive smokers in Russia: A cross-sectional study. PLoS One. 2018;13(2):e0189207. doi: 10.1371/journal.pone.0189207. eCollection 2018. PubMed PMID: 29408935; PubMed Central PMCID: PMC5800551.
Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat. 2018 Feb;85:90-96. doi: 10.1016/j.jsat.2017.07.001. Epub 2017 Jul 3. PubMed PMID: 28733097; PubMed Central PMCID: PMC5750108.
Kim TW, Walley AY, Ventura AS, Patts GJ, Heeren TC, Lerner GB, Mauricio N, Saitz R. Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence. AIDS Care. 2018 Feb;30(2):150-159. doi: 10.1080/09540121.2017.1384532. Epub 2017 Oct 16. PubMed PMID: 29034725; PubMed Central PMCID: PMC5977400.
Lorkiewicz SA, Ventura AS, Heeren TC, Winter MR, Walley AY, Sullivan M, Samet JH, Saitz R. Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection. Subst Abus. 2018 Jan 2;39(1):116-123. doi: 10.1080/08897077.2017.1391925. Epub 2017 Dec 5. PubMed PMID: 29058572; PubMed Central PMCID: PMC5979270.
Idrisov B, Lunze K, Cheng DM, Blokhina E, Gnatienko N, Quinn E, Bridden C, Walley AY, Bryant KJ, Lioznov D, Krupitsky E, Samet JH. Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia. Addict Sci Clin Pract. 2017 Dec 4;12(1):30. doi: 10.1186/s13722-017-0098-5. PubMed PMID: 29198185; PubMed Central PMCID: PMC5713116.
Idrisov B, Lunze K, Cheng DM, Blokhina E, Gnatienko N, Patts GJ, Bridden C, Kleinman RE, Weiser SD, Krupitsky E, Samet JH. Food Insecurity, HIV Disease Progression and Access to Care Among HIV-Infected Russians not on ART. AIDS Behav. 2017 Dec;21(12):3486-3495. doi: 10.1007/s10461-017-1885-4. PubMed PMID: 28822002; PubMed Central PMCID: PMC5705384.
Kim TW, Walley AY, Heeren TC, Patts GJ, Ventura AS, Lerner GB, Mauricio N, Saitz R. Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence. J Subst Abuse Treat. 2017 Oct;81:1-10. doi: 10.1016/j.jsat.2017.07.007. Epub 2017 Jul 14. PubMed PMID: 28847449; PubMed Central PMCID: PMC5966024.
Edelman EJ, Lunze K, Cheng DM, Lioznov DA, Quinn E, Gnatienko N, Bridden C, Chaisson CE, Walley AY, Krupitsky EM, Raj A, Samet JH. HIV Stigma and Substance Use Among HIV-Positive Russians with Risky Drinking. AIDS Behav. 2017 Sep;21(9):2618-2627. doi: 10.1007/s10461-017-1832-4. PubMed PMID: 28634662; PubMed Central PMCID: PMC5856479.
Nolan S, Walley AY, Heeren TC, Patts GJ, Ventura AS, Sullivan MM, Samet JH, Saitz R. HIV-infected individuals who use alcohol and other drugs, and virologic suppression. AIDS Care. 2017 Sep;29(9):1129-1136. doi: 10.1080/09540121.2017.1327646. Epub 2017 May 17. PubMed PMID: 28513200; PubMed Central PMCID: PMC5543330.
What would you like to do?